Entelar Signs Reseller Agreement with Radware
Entelar to offer Radware’s application and network security solutions AUCKLAND, New Zealand and MAHWAH, N.J.,…
4 years ago
Wire Stories
Fintech Kinara Capital Secures USD $50 Million in Equity, Led by Nuveen
Fresh Equity Round comes from Nuveen’s Global Impact Fund and Triple Jump’s ASN Microkredietfonds Kinara…
4 years ago
BeiGene Presents Updated Results from Phase 3 RATIONALE-309 Trial of PD-1 Inhibitor Tislelizumab in First-Line RM-NPC in Virtual ASCO Plenary Series
Progression-Free Survival Benefit of Tislelizumab in Combination with Chemotherapy Sustained at Median 15.5 Month Follow-up…
4 years ago
Turnstone Biologics Announces Executive Leadership Appointments
Additions of Venkat Ramanan, Ph.D., as Chief Financial Officer and P. Joseph Campisi Jr., J.D.,…
4 years ago
Librestream’s Remote Collaboration Solution Takes the Lead in Supporting Global Energy Transformation Goals
Librestream’s Onsight solution, the leading augmented reality platform, set to support ReNew Power’s sustainability and…
4 years ago
GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities
- Newest Combination Strengthens GC’s Unique Value Proposition for the Fastest Growing CDMO market YONGIN,…
4 years ago
GNCO Launches PUPEE BOARD, Smart Self-cleaning Dog Potty
GOYANG, South Korea--(BUSINESS WIRE)--#CleaningDogWaste--Gamja n Company (GNCO), a hardware startup from South Korea, has finally…
4 years ago
MYPINPAD and SmartPesa Merge to Become the Global Leader in Mobile Payments Acceptance
LONDON & SINGAPORE--(BUSINESS WIRE)--MYPINPAD, a global leader in mobile-based payments acceptance and digital authentication solutions,…
4 years ago
Juniper Research: Regtech to Account for Over 50% of Regulatory Compliance Spend Globally by 2026, as AI Reshapes Digital Onboarding
BASINGSTOKE, England--(BUSINESS WIRE)--#regtechmarket--A new study from Juniper Research has found that global regtech spend will…
4 years ago
ENHERTU® Granted Priority Review in the U.S. for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer
Based on pivotal DESTINY-Lung01 results showing Daiichi Sankyo and AstraZeneca’s ENHERTU demonstrated a 54.9% tumor…
4 years ago